Ayer Capital Management
Latest statistics and disclosures from Ayer Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Lion Biotechnologies, Oncothyreon, and represent 100.00% of Ayer Capital Management's stock portfolio.
- Reduced shares in these 1 stock: Lion Biotechnologies (-$26M).
- Ayer Capital Management was a net seller of stock by $-26M.
- Ayer Capital Management has $27M in assets under management (AUM), dropping by -60.71%.
- Central Index Key (CIK): 0001471149
Portfolio Holdings for Ayer Capital Management
Ayer Capital Management holds 2 positions in its portfolio as reported in the June 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Lion Biotechnologies | 96.5 | $26M | -49% | 2.8M | 9.17 |
|
| Oncothyreon | 3.5 | $935k | 250k | 3.74 |
|
Past Filings by Ayer Capital Management
SEC 13F filings are viewable for Ayer Capital Management going back to 2010
- Ayer Capital Management 2015 Q2 filed Aug. 14, 2015
- Ayer Capital Management 2015 Q1 filed May 20, 2015
- Ayer Capital Management 2014 Q2 filed Aug. 14, 2014
- Ayer Capital Management 2014 Q1 filed May 15, 2014
- Ayer Capital Management 2013 Q4 filed Feb. 18, 2014
- Ayer Capital Management 2013 Q3 filed Nov. 14, 2013
- Ayer Capital Management 2013 Q2 filed Aug. 16, 2013
- Ayer Capital Management 2013 Q1 filed May 16, 2013
- Ayer Capital Management 2012 Q4 filed Feb. 14, 2013
- Ayer Capital Management 2012 Q3 filed Nov. 15, 2012
- Ayer Capital Management 2012 Q2 filed Aug. 16, 2012
- Ayer Capital Management 2012 Q1 filed May 15, 2012
- Ayer Capital Management 2011 Q3 filed Nov. 14, 2011
- Ayer Capital Management 2011 Q2 filed Aug. 15, 2011
- Ayer Capital Management 2011 Q1 filed May 17, 2011
- Ayer Capital Management 2010 Q4 filed Feb. 15, 2011